BARBIROLI, BRUNO
 Distribuzione geografica
Continente #
NA - Nord America 6.291
AS - Asia 5.706
EU - Europa 5.313
AF - Africa 352
SA - Sud America 279
Continente sconosciuto - Info sul continente non disponibili 273
OC - Oceania 13
Totale 18.227
Nazione #
US - Stati Uniti d'America 6.160
CN - Cina 1.608
GB - Regno Unito 1.607
VN - Vietnam 1.585
SG - Singapore 1.408
DE - Germania 838
IT - Italia 653
UA - Ucraina 478
SE - Svezia 473
HK - Hong Kong 390
FR - Francia 340
IN - India 284
RU - Federazione Russa 280
BR - Brasile 198
IE - Irlanda 182
JP - Giappone 107
EE - Estonia 99
ZA - Sudafrica 99
CA - Canada 90
CI - Costa d'Avorio 86
FI - Finlandia 74
NL - Olanda 74
KR - Corea 71
SC - Seychelles 69
AT - Austria 62
TG - Togo 53
AR - Argentina 37
BD - Bangladesh 30
PH - Filippine 28
NG - Nigeria 25
JO - Giordania 24
CH - Svizzera 23
TH - Thailandia 23
BE - Belgio 22
BG - Bulgaria 22
IR - Iran 22
ES - Italia 18
ID - Indonesia 16
UZ - Uzbekistan 16
GR - Grecia 15
MX - Messico 14
TR - Turchia 14
HR - Croazia 12
TW - Taiwan 12
CL - Cile 11
PK - Pakistan 11
PL - Polonia 11
SA - Arabia Saudita 11
LB - Libano 9
AU - Australia 8
EC - Ecuador 8
IQ - Iraq 7
PT - Portogallo 7
CO - Colombia 6
CR - Costa Rica 6
CZ - Repubblica Ceca 6
PE - Perù 6
VE - Venezuela 6
MY - Malesia 5
NZ - Nuova Zelanda 5
PR - Porto Rico 5
PY - Paraguay 5
RO - Romania 5
KZ - Kazakistan 4
SY - Repubblica araba siriana 4
AO - Angola 3
DO - Repubblica Dominicana 3
HN - Honduras 3
JM - Giamaica 3
KE - Kenya 3
MA - Marocco 3
PS - Palestinian Territory 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
DK - Danimarca 2
DZ - Algeria 2
EG - Egitto 2
LK - Sri Lanka 2
NP - Nepal 2
OM - Oman 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BQ - ???statistics.table.value.countryCode.BQ??? 1
BW - Botswana 1
BY - Bielorussia 1
CM - Camerun 1
CY - Cipro 1
ET - Etiopia 1
EU - Europa 1
GA - Gabon 1
GT - Guatemala 1
HU - Ungheria 1
IL - Israele 1
Totale 17.951
Città #
Southend 1.409
Singapore 935
Chandler 525
Ashburn 507
Ann Arbor 433
Dong Ket 408
Hong Kong 369
Jacksonville 354
Fairfield 327
San Jose 325
Princeton 253
Hefei 241
Ho Chi Minh City 234
Hanoi 229
Houston 224
Wilmington 223
Council Bluffs 210
Santa Clara 203
Beijing 194
Dublin 180
Boardman 165
Woodbridge 164
Frankfurt am Main 156
Seattle 125
Cambridge 121
Padova 113
Westminster 112
Lauterbourg 108
Nanjing 98
Tokyo 97
Los Angeles 92
Abidjan 86
Berlin 86
Jinan 83
Medford 79
Saint Petersburg 71
Milan 69
New York 68
Helsinki 65
Buffalo 63
Mülheim 57
Shenyang 56
Seoul 54
Lomé 53
Bologna 46
Vienna 46
Da Nang 45
Mahé 45
Tianjin 45
Changsha 42
Guangzhou 42
Dallas 37
Haiphong 34
Hebei 33
San Diego 33
Toronto 33
Turin 33
Nanchang 32
Redondo Beach 32
Verona 30
Shanghai 28
São Paulo 27
Jiaxing 26
Amman 24
Zhengzhou 24
Abeokuta 23
Redwood City 23
Rome 23
Bengaluru 22
Brussels 22
Elora 21
Munich 21
Hangzhou 20
Norwalk 20
Sofia 20
Olalla 19
Bern 18
The Dalles 18
Bremen 17
Phoenix 17
Florence 16
San Francisco 16
Atlanta 15
Dearborn 15
Des Moines 15
London 15
Bühl 14
Haikou 14
Hải Dương 13
Shijiazhuang 13
Brooklyn 12
Fuzhou 12
Ningbo 12
Montreal 11
Shenzhen 11
Taizhou 11
Tongling 11
Chicago 10
Costa Mesa 10
Falls Church 10
Totale 11.321
Nome #
Accuracy of MRI/MRSI-based transrectal ultrasound biopsy in peripheral and transition zones of the prostate gland in patients with prior negative biopsy 342
Proton MR spectroscopy (1H-MRS), diffusion weighted imaging (DWI) and ultrasonography (US) in neonatal hypoglicaemia: a case report. 335
Proton MR spectroscopy (1H-MRS) and amplitude integrated EEG (aEEG) in predicting outcome in term newborns affected by hypoxic-ischemic encephalopathy (HIE). 327
Configurazioni di bobina di superficie a radiofrequenza per apparecchiatura di risonanza magnetica con migliorata sensibilita e selettività spaziale, ed apparecchiatura di risonanza magnetica comprendente una tale bobina 252
Brain diffusion-weighted imaging in Friedreich's ataxia. 250
Defective Mitochondrial Adenosine Triphosphate Production in Skeletal Muscle From Patients With Dominant Optic Atrophy Due to OPA1 Mutations 248
Radio frequency surface coil designs for magnetic resonance apparatus with improved spatial sensitivity and selectivity, and a magnetic resonance apparatus including said coil 247
Abnormal ADC in the brain of prion disease patients: variation between brain structures. 247
Prostate cancer: sextant localization with MR imaging, MR spectroscopy, and 11C-choline PET/CT. 242
Clinical and neuroimaging evidence of interictal cerebellar dysfunction in FHM2. 231
Apparent diffusion coefficient of the superior cerebellar peduncle differentiates progressive supranuclear palsy from Parkinson's disease 228
A Study of the B1 Sensitivity Dependence of Transverse Field RF Surface Coils From the Spatial Orientation 225
The ND1 gene of complex I is a mutational hot spot for Leber's hereditary optic neuropathy. 219
A novel Transverse Field RF Surface Coil for Clinical 1.5 T MRI and MRS Applications. 206
Brain & Skeletal Muscle MRS Study in Patients with Myotonic Dystrophy Type 1 204
A case of fragile X premutation tremor/ataxia syndrome (FXTAS) with evidence of mitochondrial dysfunction 197
ADC and Proton Spectroscopy Reflect Cellular Pathology in Patients with Creutzfeldt-Jakob Disease 196
A novel Transverse Field RF Surface Coil for Clinical 1.5 T MRI and MRS Applications. 195
PET-TC con 11C-colina e Spettroscopia di Risonanza Magnetica nella diagnosi e localizzazione del tumore prostatico: confronto con l'analisi seriata dello specimen chirurgico. 191
11C-Choline PET/TC for tumor localization of primary prostate cancer: comparison with 3-D proton MR spectroscopic imaging using radical prostatectomy specimen as standard of reference 191
Brain Diffusion Weighted Imaging (DWI) Study of Friedreich's Ataxia Patients 189
31P- and 1H-MR spectroscopy studies in Familial Hemiplegic Migraine type 2 (FHM2). 184
Reduced in Vivo thalamic N-Acetyl-Aspartate is a Diagnostic Marker of Prion Disease 182
TOMOGRAFIA AD EMISSIONE DI POSITRONI CON 11-C-COLINA INTEGRATO A UN SISTEMA TC (11-C-CHOLINE-PET/TC) E RISONANZA MAGNETICA DI SPETTROSCOPIA DEL PROTONE (1-H-MRSI) NELLA DIAGNOSI DI NEOPLASIA PROSTATICA: STUDIO COMPARATIVO 177
An in vivo proton magnetic resonance spectroscopy study of thalamus in prion disease 177
Quantitative mathematical expressions for accurate in vivo assessment of cytosolic [ADP] and deltaG of ATP hydrolysis in the human brain and skeletal muscle. 176
MR spectroscopy study of hypothalamic metabolism in narcolepsy and cluster headache. 176
Improved 1.5 T Magnetic Resonance Spectroscopy in the Human Calf with a Spatially Selective Radio Frequency Surface Coil 176
La risonanza magnetica di diffusione differenzia la degenerazione corticobasale dalla paralisi sopranucleare progressiva e dalla malattia di Parkinson. 176
Prostate biopsy directed on the basis of 3-D proton MR Spectroscopic Imaging findings in patients with prior negative biopsy 175
Distribution of Diffusivity Changes in Subcortical Deep Gray Matter in Prion Diseases 175
Pitfalls and advantages of different strategies for the absolute quantification of N-acetyl aspartate, creatine and choline in white and grey matter by 1H-MRS. 174
Proton MR Spectroscopy (1H-MRS) and ampltude integrated EEG on predicting outcome in newborns affected by Hypoxic-Ischemic Encephalopathy (HIE) 173
An in vivo proton magnetic resonance spectroscopy study of brain metabolism in early-onset Parkinson’s disease 173
The monoexponential pattern of phosphocreatine recovery after muscle exercise is a particular case of a more complex behaviour. 173
Cerebellar proton mr spectroscopy study in friedreich’s ataxia patients 172
The 13042G>A/ND5 mutation in mtDNA is pathogenic and can be associated also with a prevalent ocular phenotype. 171
Randomized, placebo-controlled, double-blind pilot trial of ramipril in McArdle's disease 171
Distribution of neurochemical abnormalities in patients with narcolepsy with cataplexy: an in vivo brain proton MR spectroscopy study. 171
Proton Magnetic Resonance Spectroscopy Study of Brain Metabolism in Obstructive Sleep Apnoea Syndrome before and after Continuous Positive Airway Pressure Treatment 168
Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the Parkinson variant of MSA from Parkinson’s disease and progressive supranuclear palsy. 168
Effect of glutamine/glutamate increase on the N-acetylaspartate quantification in patients with hepatic encephalopathy assessed by 1H-MRS. 167
ADC Measurements in the Middle Cerebellar Peduncle Allows the Differentiation of MSA from PD and PSP 167
Diffusion-weighted imaging study of patients with essential tremor. 166
Sextant localization of prostate cancer with 11-C-choline PET/CT: comparison with three-dimensional proton MR spectroscopic imaging using step section histopathology as standard of references 165
Dominant Optic Atrophy (DOA) and Sensorineural Hearing Loss: Clinical, Biochemical, Spectroscopic and Molecular Genetic Study of a Large Italian Pedigree Linked to a New Locus on Chromosome 16 164
Sextant localization of prostate cancer:comparison between Magnetic Resonance Spectroscopic Imaging and 11C-Choline PET-CT. 164
Pathologic correlates of diffusion MRI changes in Creutzfeldt-Jakob disease 164
Deficit of in vivo mitochondrial ATP production in patients with OPA1-related autosomal dominant optic atrophy. A 31P-MRS study of the skeletal muscle. 163
Versatile coil design and positioning of transverse-field RF surface coils for clinical 1.5-T MRI applications. 163
Diffusion Weighted Imaging Study of Patients with Essential Tremor 161
Magnetic resonance diagnostic markers in clinically sporadic prion disease: a combined brain magnetic resonance imaging and spectroscopy study. 161
Diffusion weighted imaging differentiates corticobasal degeneration from progressive supranuclear palsy and Parkinson’s disease. 161
Use of in vivo proton magnetic resonance spectroscopy in the differential diagnosis of prion diseases 160
Brain Diffusion Weighted Imaging Study of Friedreich Ataxia Patients 158
In vivo evidence of neuronal loss in the hypothalamus of narcoleptic patients. 156
PET/TC CON 11-C-COLINA E SPETTROSCOPIA DO RISONANZA MAGNETICA NELLA DIAGNOSI E LOCALIZZAZIONE DEL TUMORE PROSTATICO: CONFRONTO CON LA ANALISI SERIATA DELLO SPICIMEN CHIRURGICO 156
Prion disease: an in vivo proton magnetic resonance spectroscopy study of thalamus. 155
Diffusion weighted imaging study of patients with essential tremor. 155
The role of pH on the thermodynamics and kinetics of muscle biochemistry: an in vivo study by (31)P-MRS in patients with myo-phosphorylase deficiency. 153
Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's disease. 152
Sextant localization of prostate cancer with 11-C-choline PET/CT: comparison with three-dimensional proton MR spectroscopic imaging using step section histopathology as standard of references 150
Cytosolic pH buffering during exercise and recovery in skeletal muscle of patients with McArdle’s disease 150
The complex relationship between magnesium and serum parathyroid hormone: a study in patients with chronic intestinal failure 147
Diffusion weighted imaging study of patients with essential tremor. 147
Carotid artery stenting: the high rate of silent cerebral embolic lesions on DWI is associated with aortic arch morphology 146
SEXTANT LOCALIZATION OF PROSTATE CANCER WITH 11C-CHOLINE PET/CT: COMPARISON WITH THREE-DIMENSIONAL PROTON MR SPECTROSCOPIC IMAGING USING STEP SECTION HISTOPATHOLOGY AS STANDARD OF REFERENCES 145
Deficit of in vivo mitochondrial ATP production in OPA1-related dominant optic atrophy. 143
Autosomal dominant optic atrophy (ADO): different OPA1 mutations result in a deficit of in vivo mitochondrial ATP production 140
Apparent diffusion coefficient of the superior cerebellar peduncle differentiates progressive supranuclear palsy from PD 139
Free Mg2+concentration in the calf muscle of glycogen phosphorylase and phosphofructokinase deficiency patients assessed in different metabolic conditions by 31P MRS. 138
OPA1 Mutations Result in a Deficit of In Vivo Mitochondrial ATP Production in Patients with Autosomal Dominant Optic Atrophy 138
Diffusion-weighted imaging differentiates corticobasal degeneration from progressive supranuclear palsy and Parkinson’s disease. 138
Diffusion MRI shows increased water apparent diffusion coefficient in the brains of cirrhotics. 138
Free Mg2+ concentration in the calf muscle of patients with glycogen phosphorylase and phosphofructokinase deficiency. A 31P MRS study in different metabolic conditions. 136
Secondary Involvement of Optic Radiation in Leber’s Hereditary Optic Neuropathy 136
Friedreich’s ataxia: an in vivo proton MR spectroscopy study of the cerebellum. 134
Diffusion tensor MRI changes in cerebellar structures of patients with familial essential tremor 134
Diffusion Weighted Imaging (DWI) study of patients with essential tremor. 134
Combined DWI and 1H- MRS of the Brain of Cirrothic Patients 133
Proton MR Spectroscopy study of the cerebellum in Friedreich’s ataxia patients 131
Energy metabolism in migraine 130
Assessment of glutamate and glutamine contribution to in vivo N-acetylaspartate quantification in human brain by 1H-Magnetic Resonance Spectroscopy 130
Improved Proton MRS at 1.5 T with a Transverse Field RF Surface Coil. 126
Deficit of in vivo mitochondrial ATP production in patients with OPA1-related autosomal dominant optic atrophy 124
Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiates MSA from PD and PSP. 124
Distribution Of Diffusivity Changes In Subcortical Deep Gray Matter In Prion Diseases 123
PROSTATE BIOPSY DIRECTED ON THE BASIS OF 3-DIMENSIONAL PROTON MR SPECTROSCOPIC IMAGING FINDINGS IN PATIENTS WITH PRIOR NEGATIVE BIOPSY 123
Proton MR spectroscopy (1H-MRS), diffusion weighted imaging (DWI) and ultrasonography (US) in neonatal hypoglycemia: a case report 123
Diffusion- weighted imaging discriminates MSA-P from PD 122
Pitfalls and advantages of different T2 correction strategies for the absolute quantification of Choline, N-Acetil Aspartate in human grey matter by 1H-MRS 121
Narcolepsy-cataplexy associated with precocious puberty: a new form of hypothalamic dysfunction. 119
Prion disease: diffusion-weighted mri shows abnormalities in white and deep grey matter 117
In vivo magnetic resonance diagnostic surrogate markers in prion diseases (Contract n. QLK4-CT-2002-01763) 116
Cytosolic pH Buffering in Muscle of Patients with McArdle's Disease 116
Protected Carotid Artery Stenting: High Frequency of Silent Cerebral Embolic Lesions Detected by DWI 116
In vivo evidence of neuronal loss in the hypothalamus of narcoleptic patients 108
Diffusion-weighted MRI shows abnormalities in white and deep grey matter of prion patients. 108
Early-onset Parkinson's disease: an in vivo proton MR spectroscopy study of brain metabolism. 107
In vivo assessment by 31P-MRS of skeletal muscle mitochondrial function in patients on long-term Home Parenteral Nutrition 105
Totale 16.716
Categoria #
all - tutte 49.136
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.136


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.016 0 97 137 124 170 109 59 126 62 281 454 397
2022/20232.456 278 354 184 348 191 176 56 126 387 49 210 97
2023/2024555 35 88 27 42 53 107 52 30 17 33 10 61
2024/20251.933 73 377 157 129 371 118 88 37 14 115 29 425
2025/20265.041 320 504 478 360 667 350 422 126 1.020 429 157 208
2026/2027250 88 162 0 0 0 0 0 0 0 0 0 0
Totale 18.227